BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36107107)

  • 21. Subthalamic stimulation-induced synaptic responses in substantia nigra pars compacta dopaminergic neurons in vitro.
    Iribe Y; Moore K; Pang KC; Tepper JM
    J Neurophysiol; 1999 Aug; 82(2):925-33. PubMed ID: 10444687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent synaptic inhibition of the subthalamic nucleus by high frequency stimulation.
    Steiner LA; Kühn AA; Geiger JR; Alle H; Popovic MR; Kalia SK; Hodaie M; Lozano AM; Hutchison WD; Milosevic L
    Brain Stimul; 2022; 15(5):1223-1232. PubMed ID: 36058524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excitatory drive from the Subthalamic nucleus attenuates GABAergic transmission in the Substantia Nigra pars compacta via endocannabinoids.
    Freestone PS; Wu XH; de Guzman G; Lipski J
    Eur J Pharmacol; 2015 Nov; 767():144-51. PubMed ID: 26472124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A non-cholinergic neuronal loss in the pedunculopontine nucleus of toxin-evoked parkinsonian rats.
    Pienaar IS; van de Berg W
    Exp Neurol; 2013 Oct; 248():213-23. PubMed ID: 23769975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subthalamic stimulation-induced forelimb dyskinesias are linked to an increase in glutamate levels in the substantia nigra pars reticulata.
    Boulet S; Lacombe E; Carcenac C; Feuerstein C; Sgambato-Faure V; Poupard A; Savasta M
    J Neurosci; 2006 Oct; 26(42):10768-76. PubMed ID: 17050715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complex EPSCs evoked in substantia nigra reticulata neurons are disrupted by repetitive stimulation of the subthalamic nucleus.
    Shen KZ; Johnson SW
    Synapse; 2008 Apr; 62(4):237-42. PubMed ID: 18236470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships between the prefrontal cortex and the basal ganglia in the rat: physiology of the cortico-nigral circuits.
    Maurice N; Deniau JM; Glowinski J; Thierry AM
    J Neurosci; 1999 Jun; 19(11):4674-81. PubMed ID: 10341265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low frequency stimulation of the pedunculopontine nucleus modulates electrical activity of subthalamic neurons in the rat.
    Capozzo A; Florio T; Confalone G; Minchella D; Mazzone P; Scarnati E
    J Neural Transm (Vienna); 2009 Jan; 116(1):51-6. PubMed ID: 19034381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spatial extent of β oscillatory activity in and between the subthalamic nucleus and substantia nigra pars reticulata of Parkinson's disease patients.
    Alavi M; Dostrovsky JO; Hodaie M; Lozano AM; Hutchison WD
    Exp Neurol; 2013 Jul; 245():60-71. PubMed ID: 23063495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subthalamic nucleus electrical stimulation modulates calcium activity of nigral astrocytes.
    Barat E; Boisseau S; Bouyssières C; Appaix F; Savasta M; Albrieux M
    PLoS One; 2012; 7(7):e41793. PubMed ID: 22848608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basal ganglia neural responses during behaviorally effective deep brain stimulation of the subthalamic nucleus in rats performing a treadmill locomotion test.
    Shi LH; Luo F; Woodward DJ; Chang JY
    Synapse; 2006 Jun; 59(7):445-57. PubMed ID: 16521122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basal ganglia and processing of cortical information: functional interactions between trans-striatal and trans-subthalamic circuits in the substantia nigra pars reticulata.
    Kolomiets BP; Deniau JM; Glowinski J; Thierry AM
    Neuroscience; 2003; 117(4):931-8. PubMed ID: 12654344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haloperidol-induced alteration in the physiological actions of group I mGlus in the subthalamic nucleus and the substantia nigra pars reticulata.
    Marino MJ; Awad-Granko H; Ciombor KJ; Conn PJ
    Neuropharmacology; 2002 Aug; 43(2):147-59. PubMed ID: 12213269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: electrophysiological data.
    Benazzouz A; Piallat B; Pollak P; Benabid AL
    Neurosci Lett; 1995 Apr; 189(2):77-80. PubMed ID: 7609923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of chronic levodopa treatments on the neuronal firing properties of the subthalamic nucleus and substantia nigra reticulata in hemiparkinsonian rhesus monkeys.
    Gilmour TP; Lieu CA; Nolt MJ; Piallat B; Deogaonkar M; Subramanian T
    Exp Neurol; 2011 Mar; 228(1):53-8. PubMed ID: 21146527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency-Specific Optogenetic Deep Brain Stimulation of Subthalamic Nucleus Improves Parkinsonian Motor Behaviors.
    Yu C; Cassar IR; Sambangi J; Grill WM
    J Neurosci; 2020 May; 40(22):4323-4334. PubMed ID: 32312888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat.
    Benazzouz A; Gao DM; Ni ZG; Piallat B; Bouali-Benazzouz R; Benabid AL
    Neuroscience; 2000; 99(2):289-95. PubMed ID: 10938434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of group III mGluRs inhibits GABAergic and glutamatergic transmission in the substantia nigra pars reticulata.
    Wittmann M; Marino MJ; Bradley SR; Conn PJ
    J Neurophysiol; 2001 May; 85(5):1960-8. PubMed ID: 11353013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous low-frequency deep brain stimulation of the substantia nigra pars reticulata and high-frequency stimulation of the subthalamic nucleus to treat levodopa unresponsive freezing of gait in Parkinson's disease: A pilot study.
    Valldeoriola F; Muñoz E; Rumià J; Roldán P; Cámara A; Compta Y; Martí MJ; Tolosa E
    Parkinsonism Relat Disord; 2019 Mar; 60():153-157. PubMed ID: 30241951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined STN/SNr-DBS for the treatment of refractory gait disturbances in Parkinson's disease: study protocol for a randomized controlled trial.
    Weiss D; Wächter T; Meisner C; Fritz M; Gharabaghi A; Plewnia C; Breit S; Krüger R
    Trials; 2011 Oct; 12():222. PubMed ID: 21989388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.